Essay

A journey with scientists

Daniel M. Raben
By Daniel M. Raben
May 11, 2022

We often remember how important journeys in our lives begin. I began my journey with the American Society for Biochemistry and Molecular Biology as a graduate student at Washington University in 1976 while in the biochemistry department (now the department of biochemistry and molecular biophysics).

This department had an atmosphere of excitement and discovery among the faculty, students and postdoctoral fellows. The departmental culture encouraged the free exchange of results and ideas, and we were all excited when we had the opportunity to extend these discussions to others in our own and related fields. We had two major avenues for these exchanges: publishing our results in good journals and going to national and international meetings. The two premier platforms for such exchanges were the Journal of Biological Chemistry and the ASBMB annual meeting.

This did not change for me as a postdoctoral fellow and continued when I joined the faculty at Johns Hopkins University in 1986. The high esteem for JBC and the ASBMB annual meeting was palpable among the biochemists and molecular biologists at Hopkins. Dan Lane, director of the biological chemistry department, was elected president of the ASBMB in 1990 and championed the benefits of becoming an ASBMB member. He wasn’t wrong. As I started my career, my first-choice journal was JBC, and my go-to meeting was the ASBMB annual meeting, where I met colleagues and made friends that remain in my life to this day.

In 2010, I organized a lipid-themed session for the ASBMB meeting, and I then served as a co-chair for the 2011 meeting. It was exciting for me to learn more about how the ASBMB functions and makes decisions; I was gratified to learn that the underlying motivation was to serve scientists. This applied beyond the principal mission to help scientists disseminate and discuss their results with leaders in a variety of fields and foster new interdisciplinary collaborators. The society also has a well-oiled structure to stay abreast of important trends that affect both established investigators and trainees. These include issues such as funding, job placement and career development, minority affairs, and education.

As my career developed and my associations with the ASBMB grew, I had the opportunity to become the chair of the Meetings Committee. Not surprisingly, I saw firsthand how dedicated ASBMB members can work together to organize a great annual meeting. We had the freedom to explore new ideas and structures for the meeting, adjusting to those that worked well and jettisoning those that were less successful. While committee members held differing views on various topics, it was clear that the meeting’s success was of paramount importance. It was refreshing and reaffirming to see how folks from different areas of biochemistry and molecular biology could work synergistically to put together an exciting meeting.

In addition to my work on annual meetings, I helped establish the ASBMB Lipid Research Division with Binks Wattenberg, a professor at Virginia Commonwealth University. This division, now under the direction of George Carman and Rob Stahelin, exemplifies how the ASBMB can help foster and support a field of biochemistry occupied by many society members. Its impetus came from lipid scientists who felt this diverse field lacked a platform where investigators and trainees in its subfields could form a more cohesive community and foster collaborations. The ASBMB — in particular, Barbara Gordon, then the executive director — went above and beyond any job description to help establish this division and foster a now healthy and growing community that addresses community-specific issues.

For example, many lipid investigators felt their National Institutes of Health grant proposals were placed in study sections that lacked reviewers with the lipid expertise necessary for an adequate review. This wasn’t surprising, given the interdisciplinary nature of lipid research and its impact on a variety of fields. Consequently, lipid-related proposals often were assigned to study sections that were unfamiliar with the field. To address this, the ASBMB LRD collaborated with the NIH Center for Scientific Review and provided a list of qualified lipid scientists within the ASBMB, along with their specific expertise, who were willing and able to serve on study sections. This list was shared with the scientific review officers to help them find the necessary expertise. Given the LRD’s success, more divisions are likely to develop in the future to serve other disciplines within the ASBMB community.

The ASBMB not only has been influential in my development as a scientist but also has been instrumental in fostering a vibrant scientific community. From what I can tell, there’s a lot more excitement to come.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Daniel M. Raben
Daniel M. Raben

Daniel M. Raben is a professor at the Johns Hopkins University School of Medicine and a 2021 ASBMB fellow.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Opinions

Opinions highlights or most popular articles

Evolutionary constraints on disordered proteins
Feature

Evolutionary constraints on disordered proteins

Dec. 5, 2022

Best of BMB 2022: “There’s evidence that there must be conservation of function — so how does this happen, if the sequence changes so much?”

Fun in Seattle
President's Message

Fun in Seattle

Dec. 1, 2022

#DiscoverBMB 2023: Come to Seattle for the science. Stay for the aquarium!

The f -word (failure) in research: When good plans go bad
Books

The f -word (failure) in research: When good plans go bad

Nov. 29, 2022

This is an edited excerpt from “Life and Research: A Survival Guide for Early-Career Biomedical Scientists,” a book that started as a tweet, according to its authors.

Proteins for a green energy future
Essay

Proteins for a green energy future

Nov. 20, 2022

“We need giant steps, not small, if we are going to create the innovation in policies, political will, and technology needed to succeed with this existential problem,” writes Vanderbilt’s Borden Lacy.

A glimpse into the world of lipids
Interview

A glimpse into the world of lipids

Nov. 18, 2022

ASBMB’s Deuel conference provides "a bird’s-eye view of the field."’

Advocacy successes in 2022
Funding

Advocacy successes in 2022

Nov. 17, 2022

Here’s some of what the ASBMB Public Affairs Advisory Committee and public affairs department have been up to over the past year.